Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2003
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2482996A1 Vitamin d3 upregulated protein 1 treats post-infarct myocardial ischemia
11/05/2003EP1358485A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358348A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358342A2 Retroviral vectors for transduction into quiescent cells and packaging systems for them
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358210A2 Adhesion molecules
11/05/2003EP1358208A2 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1357978A2 Hematopoietic stem cell gene therapy
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003EP1357931A2 Keratinocyte growth factor-2
11/05/2003EP1105141B1 Phosphatidylcholine as a medicament for the protection of mucosa
11/05/2003EP1037670B1 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
11/05/2003EP0994945B1 Smad-interacting polypeptides and their use
11/05/2003EP0960197A4 GENES FROM 20q13 AMPLICON AND THEIR USES
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003EP0699073B1 xenogeneic transplantation
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454264A The method of detecting mutant DSPP gene of hereditary opalescent dentin
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453361A Construction method of virus as anticancer targeting adjustable gene
11/05/2003CN1453039A Method of speeding wound repair and preventing complications
11/05/2003CN1452984A Prepn of influenza-preventing antiserum
11/05/2003CN1126816C Method for large scale production of recombined-adenovirus accompanying virus and application thereof
11/04/2003US6642433 Nucleic acid construct comprising a promoter, marker and nucleotide sequence; producing animals with decreased gene expression and increased survival when infected with hepatitis virus; allograph rejection, fetal loss inflammatory bowel
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642368 Programmed cell death and caspase-12
11/04/2003US6642367 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
11/04/2003US6642208 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
11/04/2003US6642207 Artificial chromosome constructs containing foreign nucleic acid sequences
11/04/2003US6642052 Generating genetically engineered viral particle; obtain viral genome, incubate with regulatory sequences, allow homologous recombination transfect cells, recover genetically engineered viral particle
11/04/2003US6642051 Rep and/or cap gene linked to a nucleotide sequence; high-titer; use in gene therapy
11/04/2003US6642028 Isolated DNA encoding a Factor VIII protein; consensus splice sites which have been corrected relative to those of given nucleotide sequence
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642006 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system, vision, kidney and liver disorders
11/04/2003US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641815 Sequestrin
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of
10/2003
10/30/2003WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
10/30/2003WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089618A2 Transposon system and methods of use
10/30/2003WO2003089613A2 Tocopherol associated protein and uses thereof
10/30/2003WO2003089612A2 IMPROVED rAAV VECTORS
10/30/2003WO2003089609A2 Short fragment homologous replacement to provide bse resistant cattle
10/30/2003WO2003089600A2 Surface transfection and expression procedure
10/30/2003WO2003089596A2 Novel prostate tumor-specific promoter
10/30/2003WO2003089590A2 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003WO2003089453A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
10/30/2003WO2003089046A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003WO2003089011A1 rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088899A2 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof
10/30/2003WO2003088812A2 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003049783A3 Device and methods for harvesting tissue samples of known geometry
10/30/2003WO2003049700B1 Growth hormone releasing hormone suplementation for treating chronically ill subjects
10/30/2003WO2003037370A3 Anthrax antigenic compositions
10/30/2003WO2003035849A3 Methods for gene transfer using pseudotyped lentiviruses
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003031633A3 Adenoviral vector system
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003029274A3 Paramyxoviruses as gene transfer vectors to lung cells
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003022040A3 Method for producing transgenic animals
10/30/2003WO2003020309A3 Compound
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018821A3 Compositions and methods for treating neurodegenerative diseases
10/30/2003WO2003018815A3 Regulation of human g protein-couple receptor kinase
10/30/2003WO2003012051A3 Inhibitor of dna methylation
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002099041A3 Ces2s as modifiers of the p53 pathway and methods of use
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002095038A3 Vectors for enhanced expression of vegf for disease treatment
10/30/2003WO2002093519A3 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
10/30/2003WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 870